Lakeisha Demerson, MD
Obstetrics & Gynecology · Dallas, TXNPI 1346479318
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,069 of the $10,830 with a category attached, or 65.3%. Intuitive Surgical accounts for 66.8% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2023 at $6,964 and has fallen 92.3% since, to $540 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $55.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Astellas Pharma US Inc$461
- AbbVie$426
- Pfizer$391
- Biogen$321
- Mayne Pharma Commercial LLC$312
- plus $2K from 24 others
What the payments were for
- Travel & lodging$2312%
- Food & beverage$3,53133%
- Education$7,06965%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $7,231 |
| Astellas Pharma US Inc | 25 | $461 |
| AbbVie(2 entities) | 26 | $426 |
| Pfizer | 22 | $391 |
| Biogen | 14 | $321 |
| Mayne Pharma Commercial LLC | 11 | $312 |
| Hologic Sales And Service, LLC | 9 | $209 |
| Bayer | 9 | $202 |
| Sumitomo Pharma America, Inc. | 8 | $179 |
| Evofem Biosciences, Inc. | 9 | $174 |
| Amgen | 11 | $165 |
| Organon | 6 | $118 |
| Millicent US Inc | 5 | $97 |
| Exeltis, USA Inc. | 4 | $77 |
| Myriad Women's Health, Inc. | 1 | $54 |
| AMAG Pharmaceuticals, Inc. | 3 | $51 |
| Exact Sciences | 3 | $47 |
| Agile Therapeutics, Inc. | 2 | $45 |
| Covidien LP | 3 | $43 |
| Lupin Inc. | 3 | $41 |
| Merck | 2 | $33 |
| Ascend Therapeutics US, LLC | 2 | $31 |
| Coopersurgical, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Aspira Women's Health Inc | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Radius Health, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,000
- Da Vinci Surgical System$134
How this compares
$10,830 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 32 | $1,466 |
| Acyclovir | 17 | $696 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $279 |
| Alendronate Sodium | 13 | $153 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dallas
- Dale StovallDallas$590K
- Quanita CrableDallas$176K
- Kamilia SmithDallas$119K
- Yolanda LawsonDallas$96K
- Patrick WeixDallas$96K
- David RogersDallas$44K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.